T cells in crescentic glomerulonephritis

被引:144
作者
Tipping, PG [1 ]
Holdsworth, SR [1 ]
机构
[1] Monash Univ, Ctr Med, Dept Med, Monash Inst Med Res,Ctr Inflammatory Dis, Clayton, Vic 3168, Australia
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 05期
关键词
D O I
10.1681/ASN.2005091013
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Crescent formation in glomerulonephritis (GN) is a manifestation of severe glomerular injury that usually results in a poor clinical outcome. In humans, crescentic GN is frequently associated with evidence of either systemic or organ-specific autoimmunity. T cells play a major role in initiation of adaptive immune responses that lead to crescentic injury. In experimental models of crescentic GN, Th1 predominant immune responses have been shown to promote crescent formation. Perturbation of regulatory T cell function may contribute to development of autoimmune crescentic GN. The presence of T cells and macrophages in crescentic glomeruli, frequently in the absence of humoral mediators of immunity, suggest a dominant effector role for T cells in crescentic GN. The association of cellular immune mediators with local fibrin deposition implicates cell-mediated "delayed-type hypersensitivity-like" mechanisms in crescent formation. Intrinsic renal cells also contribute to T cell-driven effector mechanisms in crescentic GN, via expression of MHC II and co-stimulatory molecules and by production of chemokines and cytokines that amplify leukocyte recruitment and injury.
引用
收藏
页码:1253 / 1263
页数:11
相关论文
共 118 条
[1]   LUPUS NEPHRITIS - CORRELATION OF INTERSTITIAL-CELLS WITH GLOMERULAR FUNCTION [J].
ALEXOPOULOS, E ;
SERON, D ;
HARTLEY, RB ;
CAMERON, JS .
KIDNEY INTERNATIONAL, 1990, 37 (01) :100-109
[2]  
ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470
[3]   Monoclonal antibody analysis of crescentic membranous glomerulonephropathy [J].
Arrizabalaga, P ;
Boix, AS ;
Rabassa, AT ;
Tey, AD ;
Torrellas, LR .
AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (01) :77-82
[4]   Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis [J].
Bagavant, H ;
Tung, KSK .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :944-950
[5]   Lupus glomerulonephritis revisited 2004: Autoimmunity and end-organ damage [J].
Bagavant, H ;
Deshmukh, US ;
Gaskin, F ;
Fu, SM .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (1-2) :52-63
[6]   SHARED IDIOTYPES IN MESANGIAL DEPOSITS IN IGA NEPHROPATHY ARE NOT DISEASE-SPECIFIC [J].
BAKE, AWLV ;
BRUIJN, JA ;
ACCAVITTI, MA ;
CROWLEYNOWICK, PA ;
SCHROHENLOHER, RE ;
JULIAN, BA ;
JACKSON, S ;
KUBAGAWA, H ;
COOPER, MD ;
DAHA, MR ;
MESTECKY, J .
KIDNEY INTERNATIONAL, 1993, 44 (01) :65-74
[7]   Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis [J].
Balding, CEJ ;
Howie, AJ ;
Drake-Lee, AB ;
Savage, COS .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 125 (02) :332-339
[8]   Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice [J].
Bloom, RD ;
O'Connor, T ;
Cizman, B ;
Kalluri, R ;
Naji, A ;
Madaio, MP .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (08) :867-871
[9]  
BROUWER E, 1994, CLIN EXP IMMUNOL, V98, P448
[10]   ANTIMYELOPEROXIDASE-ASSOCIATED PROLIFERATIVE GLOMERULONEPHRITIS - AN ANIMAL-MODEL [J].
BROUWER, E ;
HUITEMA, MG ;
KLOK, PA ;
DEWEERD, H ;
TERVAERT, JWC ;
WEENING, JJ ;
KALLENBERG, CGM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :905-914